Literature DB >> 31852195

Selected sex related differences in pathophysiology of cardiovascular system.

O Kittnar1.   

Abstract

The annual incidence of cardiovascular diseases is age-dependently increasing both in men and women, however, the prevalence is higher in men until midlife. The higher incidence of cardiovascular disease in men than in women of similar age, and the menopause-associated increase in cardiovascular disease in women, has led to speculation that gender-related differences in sex hormones might have a key role in the development and evolution of cardiovascular disease. There are several suggested pathways in which gender and sex hormones can affect human cardiovascular system to produce original sexually different pathophysiology between women and men. Sex steroid hormones and their receptors are critical determinants of cardiovascular gender differences. Also arterial blood pressure is typically lower in women than in men what could be explained particularly by greater synthesis of nitric oxide (NO) in women. Female cardiomyocytes have a greater survival advantage when challenged with oxidative stress, suggesting that female hormones may play an important role in antioxidative protection of myocardium. It was also demonstrated in animal models that combination of XX chromosomes versus an XY chromosomes enhances sex differences in higher HDL cholesterol. Women were found to have reduced sympathetic activity (reflected by lower total peripheral resistance) and pulmonary artery pressure and enhanced parasympathetic activity relative to men. Similarly, men were found to have higher plasma norepinephrine levels than women. Regarding differences between the sexes in electrophysiology of the heart, two principle mechanisms have been proposed to explain them: hormonal effects on the expression or function of ion channels or, conversely, differences in autonomic tone. To improve diagnosis and treatment of cardiovascular diseases, greater focus on understanding the molecular and cellular physiology of the sex steroid hormones and their receptors in the cardiovascular system will be required.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31852195      PMCID: PMC8565954          DOI: 10.33549/physiolres.934068

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  59 in total

Review 1.  Gender, sex hormones and autonomic nervous control of the cardiovascular system.

Authors:  Anthony M Dart; Xiao-Jun Du; Bronwyn A Kingwell
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

Review 2.  [Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes].

Authors:  Alexandra Kautzky-Willer; Heidemarie Abrahamian; Raimund Weitgasser; Peter Fasching; Fritz Hoppichler; Monika Lechleitner
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 3.  Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors:  Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

Review 4.  Androgens and cardiovascular disease in women and men.

Authors:  Eleni Armeni; Irene Lambrinoudaki
Journal:  Maturitas       Date:  2017-07-29       Impact factor: 4.342

5.  Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts.

Authors:  Nathalie Gaborit; Andras Varro; Sabrina Le Bouter; Viktoria Szuts; Denis Escande; Stanley Nattel; Sophie Demolombe
Journal:  J Mol Cell Cardiol       Date:  2010-06-21       Impact factor: 5.000

6.  Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females.

Authors:  Claudia J Lagranha; Anne Deschamps; Angel Aponte; Charles Steenbergen; Elizabeth Murphy
Journal:  Circ Res       Date:  2010-04-22       Impact factor: 17.367

7.  Association of the human Y chromosome with cholesterol levels in the general population.

Authors:  Fadi J Charchar; Maciej Tomaszewski; Beata Lacka; Jaroslaw Zakrzewski; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Anna F Dominiczak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-18       Impact factor: 8.311

Review 8.  Oxidative stress and cardiovascular disease: novel tools give (free) radical insight.

Authors:  Ian M Fearon; Stephen P Faux
Journal:  J Mol Cell Cardiol       Date:  2009-05-28       Impact factor: 5.000

9.  Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.

Authors:  Amanda K Sampson; Karen L Andrews; Delyth Graham; Martin W McBride; Geoffrey A Head; Merlin C Thomas; Jaye P F Chin-Dusting; Anna F Dominiczak; Garry L Jennings
Journal:  Hypertension       Date:  2014-09-08       Impact factor: 10.190

10.  The Effects of Female Sex Hormones on Ventricular Premature Beats and Repolarization Parameters in Physiological Menstrual Cycle.

Authors:  Mehmet Dogan; Omer Yiginer; Omer Uz; Ugur Kucuk; Gokhan Degirmencioglu; Zafer Isilak; Mehmet Uzun; Ezgi Davulcu
Journal:  Pacing Clin Electrophysiol       Date:  2016-03-02       Impact factor: 1.976

View more
  8 in total

1.  NMR plasma metabolomics study of patients overcoming acute myocardial infarction: in the first 12 h after onset of chest pain with statistical discrimination towards metabolomic biomarkers.

Authors:  M Petras; D Kalenska; M Samos; T Bolek; M Sarlinova; P Racay; E Halasova; O Strbak; J Stasko; L Musak; M Skorvanova; E Baranovicova
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

2.  Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes.

Authors:  M Kreslová; A Sýkorová; R Bittenglová; J Schwarz; R Pomahačová; P Jehlička; J Kobr; L Trefil; J Sýkora
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

3.  Development of a polygenic risk score to improve detection of peripheral artery disease.

Authors:  Fudi Wang; Ilies Ghanzouri; Nicholas J Leeper; Philip S Tsao; Elsie Gyang Ross
Journal:  Vasc Med       Date:  2022-03-14       Impact factor: 4.739

4.  Abnormal Reginal Homogeneity in Left Anterior Cingulum Cortex and Precentral Gyrus as a Potential Neuroimaging Biomarker for First-Episode Major Depressive Disorder.

Authors:  Yan Song; Chunyan Huang; Yi Zhong; Xi Wang; Guangyuan Tao
Journal:  Front Psychiatry       Date:  2022-06-01       Impact factor: 5.435

5.  The role of connexin 37 polymorphism in spontaneous abortion.

Authors:  M Kníže; J Piťha; J A Hubacek; T Fait
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

6.  Association of ACE2 Polymorphisms and Derived Haplotypes With Obesity and Hyperlipidemia in Female Spanish Adolescents.

Authors:  Jairo Lumpuy-Castillo; Claudia Vales-Villamarín; Ignacio Mahíllo-Fernández; Iris Pérez-Nadador; Leandro Soriano-Guillén; Oscar Lorenzo; Carmen Garcés
Journal:  Front Cardiovasc Med       Date:  2022-05-02

Review 7.  Sex differences in hypertension. Do we need a sex-specific guideline?

Authors:  Renata Cífková; Larysa Strilchuk
Journal:  Front Cardiovasc Med       Date:  2022-08-23

8.  Can changes in skin impedance be used to monitor sedation after midazolam and during recovery from anesthesia?

Authors:  A Kurzová; L Hess; J Slíva; J Málek
Journal:  Physiol Res       Date:  2021-03-08       Impact factor: 1.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.